Should aprotinin continue to be used during cardiac surgery? Commentary
Publication
, Other
Levy, JH; Despotis, GJ; Spitznagel, E
Published in: Nature Clinical Practice Cardiovascular Medicine
July 1, 2006
Duke Scholars
Published In
Nature Clinical Practice Cardiovascular Medicine
DOI
EISSN
1743-4300
ISSN
1743-4297
Publication Date
July 1, 2006
Volume
3
Issue
7
Start / End Page
360 / 361
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., Despotis, G. J., & Spitznagel, E. (2006). Should aprotinin continue to be used during cardiac surgery? Commentary. Nature Clinical Practice Cardiovascular Medicine. https://doi.org/10.1038/ncpcardio0578
Levy, J. H., G. J. Despotis, and E. Spitznagel. “Should aprotinin continue to be used during cardiac surgery? Commentary.” Nature Clinical Practice Cardiovascular Medicine, July 1, 2006. https://doi.org/10.1038/ncpcardio0578.
Levy JH, Despotis GJ, Spitznagel E. Should aprotinin continue to be used during cardiac surgery? Commentary. Vol. 3, Nature Clinical Practice Cardiovascular Medicine. 2006. p. 360–1.
Levy, J. H., et al. “Should aprotinin continue to be used during cardiac surgery? Commentary.” Nature Clinical Practice Cardiovascular Medicine, vol. 3, no. 7, 1 July 2006, pp. 360–61. Scopus, doi:10.1038/ncpcardio0578.
Levy JH, Despotis GJ, Spitznagel E. Should aprotinin continue to be used during cardiac surgery? Commentary. Nature Clinical Practice Cardiovascular Medicine. 2006. p. 360–361.
Published In
Nature Clinical Practice Cardiovascular Medicine
DOI
EISSN
1743-4300
ISSN
1743-4297
Publication Date
July 1, 2006
Volume
3
Issue
7
Start / End Page
360 / 361
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology